147 results on '"Stinchcomb, Dan T."'
Search Results
2. Development of a recombinant, chimeric tetravalent dengue vaccine candidate
3. Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
4. CD8⁺ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate
5. Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
6. A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen
7. Preclinical Evaluation of a Live Attenuated Chikungunya Vaccine
8. Toward the Therapeutic Editing of Mutated RNA Sequences
9. High-Frequency Transformation of Yeast: Autonomous Replication of Hybrid DNA Molecules
10. par-2, a Gene Required for Blastomere Asymmetry in Caenorhabditis elegans, Encodes Zinc-Finger and ATP-Binding Motifs
11. Caenorhabditis elegans DNA That Directs Segregation in Yeast Cells
12. Eukaryotic DNA Segments Capable of Autonomous Replication in Yeast
13. Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors
14. Chikungunya virus and prospects for a vaccine
15. Limited infection upon human exposure to a recombinant raccoon pox vaccine vector
16. Recombinant raccoon pox vaccine protects mice against lethal plague
17. An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages
18. Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
19. A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika
20. Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
21. A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone
22. Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
23. CD8+T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate
24. DNA SEQUENCES THAT ALLOW THE REPLICATION AND SEGREGATION OF YEAST CHROMOSOMES
25. Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques
26. Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
27. A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
28. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
29. Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)
30. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
31. Cross-protective immunity against o‘nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
32. Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
33. Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines
34. Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
35. Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism
36. Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
37. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling
38. Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice
39. IMMUNIZATION OF BLACK-TAILED PRAIRIE DOG AGAINST PLAGUE THROUGH CONSUMPTION OF VACCINE-LADEN BAITS
40. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry
41. CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.
42. Protection of Black-Tailed Prairie Dogs (Cynomys ludovicianus) against Plague after Voluntary Consumption of Baits Containing Recombinant Raccoon Poxvirus Vaccine
43. Raccoon Poxvirus as a Mucosal Vaccine Vector for Domestic Cats
44. A rapid immunization strategy with a live attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates.
45. Anti-gene therapy: the use of ribozymes to inhibit gene function
46. Optimizing the Cell Efficacy of Synthetic Ribozymes
47. Ribozymes in gene therapy
48. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter
49. Characterization of cytokine production by the metrial gland and granulated metrial gland cells
50. PAR-2 is asymmetrically distributed and promotes association of P granules and PAR-1 with the cortex in C. elegans embryos
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.